TrialDiabetes, obesity & metabolism2021

Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes.

Silvio E Inzucchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.